E' un estratto derivato da molte piante, ad esempio saw palmetto, pigeum africanum, a cui viene attribuita azione di blocco sulla alfa reduttasi del testosterone e sul recettore citosilico del DHT.
Avrebbe quindi anche azione progestinica.
Viene da anni usato per la terapia medica dell'adenoma prostatico.
Title: beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review.
Author
Wilt TJ ; MacDonald R ; Ishani A
Address
The VA Coordinating Center of the Cochrane Collaborative Review Group in Prostatic
Diseases and Urologic Malignancies, 13/Minneapolis, VA, USA.
Source
BJU Int, 83(9):976-83 1999 Jun
Abstract
OBJECTIVES: To conduct a systematic review of the evidence for the efficacy of beta-sitosterol
in men with symptomatic benign prostatic hyperplasia (BPH). METHODS: Studies were
identified through Medlinetrade mark (1966-98), EMBASEtrade mark, Phytodok, the Cochrane
Library, bibliographies of identified trials and review articles, and contact with study
authors and pharmaceutical companies. Randomized trials were included if: men had
symptomatic BPH; plant extract preparations contained beta-sitosterols; a
control group received placebo or a pharmacological therapy; and treatment duration was
>/=30 days. Study characteristics, demographic information, enrolment criteria and
outcomes were extracted. RESULTS: Four trials comprising a total of 519 men met the
inclusion criteria. All were double-blind and lasted 4-26 weeks. Three studies used
nonglucosidic beta-sitosterols and one used a preparation that contained
only beta-sitosterol-beta-d-glucoside. Compared with placebo, beta-sitosterol
improved urinary symptom scores and flow measures. For the two studies reporting the
International Prostate Symptom Score (IPSS), the weighted mean difference (WMD) against
placebo was –4.9 IPSS points (95% confidence interval, CI,-6.3 to-3.5). The WMD for
peak urinary flow rate was 3.91 mL/s (95% CI 0.91 to 6.90, four studies) and for residual
volume the WMD was –28.62 mL (95% CI-41.42 to-15.83, four studies). Beta-sitosterol
did not reduce prostate size. The trial using pure beta-sitosterol-beta-d-glucoside
(WA184) showed no improvement in urinary flow measures. Withdrawal rates for men assigned
to beta-sitosterol and placebo were 7.8% and 8.0% (not significant),
respectively. CONCLUSION: beta-sitosterol improves urological symptoms and
flow measures. However, the existing studies are limited by short treatment duration and
lack of standardized beta-sitosterol preparations. Their long-term
effectiveness, safety and ability to prevent the complications of BPH are unknown.
Title: beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells.
Author
von Holtz RL ; Fink CS ; Awad AB
Address
Department of Physical Therapy, Exercise, and Nutrition Sciences, State University of New
York at Buffalo 14214-3000, USA.
Source
Nutr Cancer, 32(1):8-12 1998
Abstract
Epidemiological evidence has shown that men consuming a low-fat, high-fiber diet
containing high amounts of plant products have a lower risk of prostate cancer than men
consuming a Western diet. One of the main differences between these two diets is the type
of dietary fat, including dietary sterols. This study was undertaken to compare the effect
of two dietary sterols on prostate cancer cells in vitro. Beta-Sitosterol
(SIT), the most common plant sterol, and cholesterol, an animal sterol, were compared for
effect on LNCaP cell growth, differentiation, apoptosis, and sphingomyelin cycle
intermediates. Cells were treated for up to seven days with sterols delivered by a
cyclodextrin vehicle. Compared with cholesterol, SIT (16 microM) decreased growth by 24%
and induced apoptosis fourfold, which was accompanied by cell rounding and a 50% increase
in ceramide production. No effect was observed on differentiation as measured by
prostate-specific antigen and prostatic acid phosphatase, although total acid phosphatase
increased with SIT treatment for up to seven days. The results suggest that the decrease
in cell number and increase in apoptosis associated with SIT treatment are mediated by
activating the sphingomyelin cycle.
Beta-sitosterol (BSS) and its glycoside (BSSG) are sterol molecules which are synthesized by plants. When humans eat plant foods phytosterols are ingested, and are found in the serum and tissues of healthy individuals, but at concentrations orders of magnitude lower than endogenous cholesterol. Epidemiological studies have correlated a reduced risk of numerous diseases with a diet high in fruits and vegetables, and have concluded that specific molecules, including b-carotene, tocopherols, vitamin C, and flavonoids, confer some of this protective benefit. However, these epidemiologic studies have not examined the potential effect that phytosterols ingested with fruits and vegetables might have on disease risk reduction. In animals, BSS and BSSG have been shown to exhibit anti-inflammatory, anti-neoplastic, anti-pyretic, and immune-modulating activity. A proprietary BSS:BSSG mixture has demonstrated promising results in a number of studies, including in vitro studies, animal models, and human clinical trials. This phytosterol complex seems to target specific T-helper lymphocytes, the Th1 and Th2 cells, helping normalize their functioning and resulting in improved T-lymphocyte and natural killer cell activity. A dampening effect on overactive antibody responses has also been seen, as well as normalization of the DHEA:cortisol ratio. The re-establishment of these immune parameters may be of help in numerous disease processes relating to chronic immune-mediated abnormalities, including chronic viral infections, tuberculosis, rheumatoid arthritis, allergies, cancer, and auto-immune diseases.
Un prodotto di qualità che lo contiene è Anti-Sebum.
